Doctor Tilmann Kramer
Cologne University Hospital - Heart Center, Cologne (Germany)
Effects of targeted therapy on blood gas analysis in pulmonary arterial hypertension - a retrospective analysis
Event: ESC Congress 2022
Topic: Epidemiology, Prognosis, Outcome
Session: Hypertension - Epidemiology, prognosis, outcome 1
Therapeutic effects of phosphodiesterase 5 inhibitors in patients with heart failure with preserved ejection fraction (HFpEF) and combined post- and pre-capillary pulmonary hypertension (Cpc-PH).
Event: ESC Congress 2017
Topic: Chronic pulmonary hypertension
Session: Pulmonary hypertension: pathophysiology
Therapeutic potential of phosphodiesterase 5 inhibitors in patients with heart failure with preserved ejection fraction (HFpEF) and combined post- and pre-capillary pulmonary hypertension (Cpc-PH).
Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure
Topic: Pulmonary hypertension
Session: Moderated Poster session 6 - Therapy
ESC 365 is supported by
